The Visionix VX 120+ is a multimodal wavefront diagnostic instrument with integrated dry eye screening capabilities. Designed for optometry and ophthalmology practices, it combines tear film analysis, meibomian gland imaging, and tear meniscus height measurement into a single automated exam workflow. The VX 120+ enables clinicians to detect, document, and monitor dry eye syndrome alongside traditional refractive and corneal assessments, all without adding a separate device or appointment.
The VX 120+ Dry Eye measures tear film break-up time (TBUT) by projecting a ring pattern onto the ocular surface and tracking the rate of tear film disruption between blinks. Results are delivered in three clinician-ready formats:
This multi-format output supports both clinical interpretation and patient education, making it easier to explain dry eye findings during consultations.
The VX 120+ Dry Eye uses a high-definition color camera to capture detailed images of the meibomian glands and surrounding ocular structures. Images are stored in a longitudinal photo library, enabling clinicians to compare gland morphology across visits and track the progression or improvement of meibomian gland dysfunction (MGD) over time.
This documentation capability supports evidence-based treatment decisions and gives practitioners a clear visual aid for discussing dry eye status with patients.
The VX 120+ Dry Eye measures tear meniscus height (TMH) using the high-definition camera’s zoom function to precisely quantify the inferior tear film reservoir. TMH is a key biomarker for aqueous-deficient dry eye and helps differentiate dry eye subtypes to guide treatment planning.
*PhD from the University of Alicante in 2010, degree in Optics and Optometry, Documentation Science, and specialization in Pre- and Post-Surgical Optometry, with extensive clinical and scientific experience, over 100 published articles, and participation in more than 20 research projects.
From detecting glaucoma and keratoconus to pinpointing candidates for cataract surgery with premium and/or toric implants, as well as identifying optimal candidates for refractive surgery – our state-of-the-art technologies come together to provide a comprehensive suite of tools for superior eye care.
Embrace a new era in eye care with seamlessly integrated comprehensive screening and continuous monitoring capabilities for a diverse range of eye pathologies. One of these often-undervalued conditions is dry eye syndrome, which can profoundly impact patients’ quality of life.
Our innovative solution empowers you to proactively identify, track, and manage various eye pathologies, ensuring that even conditions like dry eye syndrome do not escape thorough evaluation. By adopting this advanced approach, you can offer a higher level of care and address potential issues before they escalate.
With the ability to capture subtle changes and trends over time, our technology provides a proactive way to address pathologies. By embracing comprehensive screening and continuous monitoring, you can stay ahead of the curve in detecting and managing major pathologies, ultimately enhancing your patients’ well-being and satisfaction.
We’re excited to introduce a simple yet effective tool to help you test whether your patients have been experiencing discomfort, irritation or other symptoms. Our Dry Eye Questionnaire could be the key to unlocking the answers you need to improve the way you follow your patients.
By taking just a few minutes to complete this questionnaire with your patient, you’re taking a proactive step towards maintaining optimal eye comfort and health. A total score of 6 or higher is a signal to consider discussing the symptoms with your patient. Remember, well-being is our priority.
Routine dry eye screening creates a clinical and commercial platform for expanded patient services. When dry eye is identified and documented during a standard exam, optometrists are positioned to offer:
Practices that integrate dry eye protocols report improved patient retention and higher per-visit revenue. The VX 120+ Dry Eye makes it practical to include dry eye screening in every exam without adding time or complexity to the workflow.
A Remarkable testimonial by Jorge Millán, optometrist in Spain, using VX 120 Dry Eye.
Jorge Millán, a dedicated partner and a user of Visionix’s VX 120 Dry Eye is sharing his incredible journey with the device and the transformation it has broug
This testimonial highlights his positive experiences, the benefits he observed with the VX 120 Dry Eye, and how it enhanced patient satisfaction.
See the VX 120+ Dry Eye in action! Schedule a personalized demonstration with a Visionix Clinical Application Specialist(CAS) to review how the system integrates into your exam workflow and supports your dry eye practice goals.
The VX 120+ Dry Eye measures three core dry eye parameters: tear film break-up time (TBUT), meibomian gland morphology via high-definition imaging, and tear meniscus height (TMH). These measurements are used to diagnose and classify dry eye syndrome and distinguish between aqueous-deficient and evaporative subtypes.
Unlike a standard autorefractor, which measures only refractive error, the VX 120+ is a multimodal diagnostic instrument. In addition to refraction and wavefront analysis, it captures ocular surface data including tear film quality, meibomian gland images, and topographic maps. This makes it suitable for pre-surgical screening, dry eye management, and monitoring of various pathologies.
Yes. The VX 120+ Dry Eye is designed for optometry and ophthalmology settings. It automates dry eye data collection and integrates results into a single exam report, making comprehensive dry eye screening practical in a standard optometric workflow without requiring a dedicated technician or separate appointment.